Can cell systems biology rescue drug discovery?

E C Butcher
{"title":"Can cell systems biology rescue drug discovery?","authors":"E C Butcher","doi":"10.1007/978-3-540-31339-7_8","DOIUrl":null,"url":null,"abstract":"<p><p>The focus of innovation in current drug discovery is on new targets, yet compound efficacy and safety in biological models of disease, not target selection, qualify drug candidates for the clinic. We consider a biology-driven approach to drug discovery based on screening compounds by automated response profiling in complex human cell systems-based disease models. Drug discovery through cell systems biology could significantly reduce the time and cost of new drug development.</p>","PeriodicalId":80277,"journal":{"name":"Ernst Schering Research Foundation workshop","volume":" 61","pages":"153-72"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"28","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ernst Schering Research Foundation workshop","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-540-31339-7_8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 28

Abstract

The focus of innovation in current drug discovery is on new targets, yet compound efficacy and safety in biological models of disease, not target selection, qualify drug candidates for the clinic. We consider a biology-driven approach to drug discovery based on screening compounds by automated response profiling in complex human cell systems-based disease models. Drug discovery through cell systems biology could significantly reduce the time and cost of new drug development.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
细胞系统生物学能拯救药物发现吗?
当前药物发现的创新重点是在新的靶点上,然而在疾病生物学模型中的复合疗效和安全性,而不是靶点选择,使候选药物符合临床条件。我们考虑了一种生物学驱动的药物发现方法,该方法基于基于复杂人类细胞系统疾病模型的自动反应分析筛选化合物。通过细胞系统生物学发现药物可以显著减少新药开发的时间和成本。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Experiences with dose finding in patients in early drug development: the use of biomarkers in early decision making. Genotype and phenotype relationship in drug metabolism. Clinical trials in elderly patients. Dose finding in pediatric patients. Integration of pediatric aspects into the general drug development process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1